Novel compounds that are useful for improving pharmacokinetics
摘要:
公式1的新化合物或其药用可接受的盐可以抑制细胞色素P450单加氧酶。
公开号:
US20060199851A1
作为产物:
描述:
噁唑-5-甲醇 、 N,N'-羰基二咪唑 在
氮气 作用下,
以
二氯甲烷 为溶剂,
反应 2.0h,
以to provide the title compound in a solution of CH2Cl2 which的产率得到Oxazol-5-ylmethyl 1H-imidazole-1-carboxylate
参考文献:
名称:
Compounds that are useful for improving pharmacokinetics
NOVEL COMPOUNDS THAT ARE USEFUL FOR IMPROVING PHARMACOKINETICS
申请人:Kempf Dale J.
公开号:US20100280248A1
公开(公告)日:2010-11-04
Novel compounds of formula 1
or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
式1的新化合物或其药学上可接受的盐能够抑制细胞色素P450单加氧酶。
SUBSTITUTED TETRAHYDROCYCLOPENTA[C]PYRROLES, SUBSTITUTED DIHYDROPYRROLIZINES, ANALOGUES THEREOF, AND METHODS USING SAME
申请人:Arbutus Biopharma Corporation
公开号:US20210179557A1
公开(公告)日:2021-06-17
The present invention includes novel substituted bicyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection and/or hepatitis D virus (HDV) infection in a patient.